GeneDx Corp. (WGS) Company Profile - Business Overview, Management Team & Corporate Information - Stocknear

GeneDx Corp.

NASDAQ: WGS · Real-Time Price · USD
132.54
2.28 (1.75%)
At close: Sep 05, 2025, 3:59 PM
132.54
0.00%
After-hours: Sep 05, 2025, 07:57 PM EDT

Company Description

GeneDx Holdings Corp. is a patient centered health intelligence company.

It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories.

The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs.

The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Corp.
GeneDx  Corp. logo
Country United States
IPO Date Nov 4, 2020
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 1,000
CEO Katherine A. Stueland

Contact Details

Address:
North Tower
Stamford, Connecticut
United States
Website http://www.genedx.com

Stock Details

Ticker Symbol WGS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001818331
CUSIP Number 81663L200
ISIN Number US81663L2007
Employer ID 85-1966622
SIC Code 8000

Key Executives

Name Position
Katherine A. Stueland President, Chief Executive Officer & Director
Dr. Bryan M. Dechairo Ph.D. Chief Operating Officer
Heidi C. Chen J.D. Chief Legal Officer
Kevin Feeley CPA Chief Financial Officer
Dr. Martin G. Reese Ph.D. President of Fabric Genomics
Jami Biliboaca Head of People Strategy
Melanie Duquette Chief Growth Officer

Latest SEC Filings

Date Type Title
Sep 03, 2025 4 Filing
Aug 27, 2025 4 Filing
Aug 26, 2025 SCHEDULE 13D/A [Amend] Filing
Aug 22, 2025 4 Filing
Aug 14, 2025 SCHEDULE 13G/A [Amend] Filing
Aug 07, 2025 4/A [Amend] Filing
Aug 06, 2025 SCHEDULE 13G/A [Amend] Filing
Jul 31, 2025 4 Filing
Jul 31, 2025 4 Filing
Jul 30, 2025 SCHEDULE 13G Filing